Angelo Maggio, Tiziana Rancati, Marco Gatti, Domenico Cante, Barbara Avuzzi, Cinzia Bianconi, Fabio Badenchini, Bruno Farina, Paolo Ferrari, Tommaso Giandini, Giuseppe Girelli, Valeria Landoni, Alessandro Magli, Eugenia Moretti, Edoardo Petrucci, Paolo Salmoiraghi, Giuseppe Sanguineti, Elisa Villa, Justyna Magdalena Waskiewicz, Alessia Guarneri, Riccardo Valdagni, Claudio Fiorino, Cesare Cozzarini
PURPOSE: The purpose of this study is to study the evolution of quality of life (QoL) in the first 5 years following Intensity-modulated radiation therapy (IMRT) for prostate cancer (PCa) and to determine possible associations with clinical/treatment data. MATERIAL AND METHODS: Patients were enrolled in a prospective multicentre observational trial in 2010-2014 and treated with conventional (74-80 Gy, 1.8-2 Gy/fr) or moderately hypofractionated IMRT (65-75.2 Gy, 2...
February 1, 2024: Current Oncology